ANTIMICROBIAL STEWARDSHIP STARTS WITH YOU…AND BETTER DIAGNOSTICS
Antimicrobial resistance (AMR) is threatening modern medicine, creating the potential for even a routine procedure to become life threatening. A 2022 study revealed that 1.27 million deaths occurred in a single year as a result of AMR.1 That's 1 death every 25 seconds.
“There is no time to wait. Unless the world acts urgently, antimicrobial resistance will have disastrous impact within a generation."
— United Nations Interagency Coordination Group (IACG)
bioMérieux provides the most complete solution to support antimicrobial stewardship (AMS) initiatives. We offer a unique and comprehensive range of actionable diagnostics, advanced analytics, consultancy services and educational modules that enable the lab and clinicians to provide earlier, optimized and data-driven therapy for better patient management and a responsible use of antibiotics.
How Could a Complete Solution for
Antimicrobial Stewardship Benefit Your Facility?
Hear how bioMérieux's unique end-to-end solution enables optimized use of diagnostics for optimized therapy along the entire patient care pathway.
INITIATION ZONE: Diagnostics Support Early Decision Making
When a patient presents at a healthcare system with infectious disease symptoms, bioMérieux's integrated diagnostic and data-driven solutions can support empiric treatment and help identify pathogens to support evidence-based decision-making.
Want to Reduce Time to Effective Treatment?
Activate Antimicrobial Stewardship With Diagnostic-Driven Data During Initiation
bioMérieux is pushing the boundaries of microbiology, giving patient results sooner and making those results more meaningful with advanced analytics and collaborative tools, like antibiograms. Listen as clinical experts discuss how to activate AMS during therapy initiation.
OPTIMIZATION ZONE: Diagnostics Drive Treatment Adjustments
Fast and actionable diagnostics and data technology enable clinicians to modify therapy— escalating, de-escalating or changing antibiotics to ensure effective treatment of the bacteria responsible for the infection. bioMérieux's complete solution, used especially in a team approach, can help guide patient management—including therapy decisions.
Want to Achieve Better Patient Ouctomes?
Accelerate Antimicrobial Stewardship With Integrated Diagnostic Solutions
During Optimization
bioMérieux's integrated solutions for AMS foster seamless partnership from the laboratory to frontline patient care. Listen to clinical experts discuss how to accelerate AMS during therapy optimization with proven diagnostic and data-driven solutions.
Uniting the Lab and Clinician for Improved Antimicrobial Stewardship
The global overuse and misuse of antibiotics continues at varying degrees and collectively threatens patient health and the financial stability of healthcare systems. Could improved collaboration from the lab to clinical care be the key to advancing AMS? bioMérieux explores how evolved application of diagnostics and data could change the game for collaborative AMS.
Read This Site Exclusive Article
DISCONTINUATION ZONE: Diagnostics Help Safely End Treatment
Antibiotics should be discontinued as soon as safely possible to avoid potential side effects and the emergence of resistant bacteria. bioMérieux's diagnostic solutions offer clinicians objective information that, along with clinical assessment, help them decide if and when they can safely stop antibiotic treatment.
Want Shorter Hospital Stays and Reduced Healthcare-Associated Costs?
Advance Antimicrobial Stewardship With Diagnostic Evidence During Discontinuation
bioMérieux offers the most complete diagnostic solution to support patient care, including the safe discontinuation of antibiotic treatment. Listen to clinical experts discuss how to advance AMS during therapy discontinuation with diagnostics and data.
READY TO PROPEL YOUR STEWARDSHIP INITIATIVES FORWARD?
Let's Connect! Fill out the form below, and a local bioMérieux expert will reach out to discuss what AMS solutions could help you achieve your goals.
bioMérieux’s Diverse Resources Support Your Stewardship Initiatives
Learn more about our initiatives to preserve antimicrobial efficacy for future generations.
Explore on-demand education, timely thought leadership, and diagnostic solutions supporting the fight against AMR.
Thought-provoking articles on scientific news, advancements, important issues, and much more.
1Thompson T. The staggering death toll of drug-resistant bacteria. Nature. Published online January 31, 2022. doi:https://doi.org/10.1038/d41586-022-00228-x